Cargando…
Overcoming a species-specificity barrier in development of an inhibitory antibody targeting a modulator of tumor stroma
The secreted disulfide catalyst Quiescin sulfhydryl oxidase-1 (QSOX1) affects extracellular matrix organization and is overexpressed in various adenocarcinomas and associated stroma. Inhibition of extracellular human QSOX1 by a monoclonal antibody decreased tumor cell migration in a cell co-culture...
Autores principales: | Grossman, Iris, Ilani, Tal, Fleishman, Sarel Jacob, Fass, Deborah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4795942/ https://www.ncbi.nlm.nih.gov/pubmed/26819240 http://dx.doi.org/10.1093/protein/gzv067 |
Ejemplares similares
-
cis‐Proline mutants of quiescin sulfhydryl oxidase 1 with altered redox properties undermine extracellular matrix integrity and cell adhesion in fibroblast cultures
por: Javitt, Gabriel, et al.
Publicado: (2018) -
Correction: Inhibition of fibroblast secreted QSOX1 perturbs extracellular matrix in the tumor microenvironment and decreases tumor growth and metastasis in murine cancer models
por: Feldman, Tal, et al.
Publicado: (2020) -
Inhibition of fibroblast secreted QSOX1 perturbs extracellular matrix in the tumor microenvironment and decreases tumor growth and metastasis in murine cancer models
por: Feldman, Tal, et al.
Publicado: (2020) -
Low-dose radiation treatment enhances systemic antitumor immune responses by overcoming the inhibitory stroma
por: Barsoumian, Hampartsoum B, et al.
Publicado: (2020) -
The disulfide catalyst QSOX1 maintains the colon mucosal barrier by regulating Golgi glycosyltransferases
por: Ilani, Tal, et al.
Publicado: (2022)